Marie-Paule Kieny Explained

Marie-Paule Kieny
Nationality:French
Alma Mater:University of Montpellier; University of Strasbourg

Marie-Paule Kieny is a French virologist, vaccinologist, public health expert and science writer. She is currently director of research at INSERM and chief of the board at DNDi.

Education

Kieny completed her PhD in microbiology in 1980 at the University of Montpellier, and received her Habilitation à Diriger des Recherches in 1995 from the University of Strasbourg.[1]

Kieny was presented with an honorary doctorate from the Autonomous University of Barcelona in 2019 for her commitment to public health and worldwide universal health care.[2] [3] [4] [5]

Career

After completing her PhD, Kieny took up a position at Transgene SA, Strasbourg, as assistant scientific director under scientific director Jean-Pierre Lecocq until 1988.

Kieny became director of research at Inserm for the first time between 1999 and 2000. Kieny was a member of the European Vaccine Initiative until 2010.[6]

Kieny was vaccine research director of WHO from 2002 to 2010, most notably during the 2009 swine flu pandemic.[7] [8] She was promoted to assistant director-general, playing a major leadership role during the Ebola virus epidemic in West Africa and the 2015–16 Zika virus epidemic.[9] [10] [11] [12] Kieny even audaciously signed up herself as a test subject for the safety of new Ebola vaccines being developed, amidst concerns over the logistics and ethics of testing early-stage therapeutics and preventatives for ebola in the context of an ongoing epidemic.[13] [14] Given the slow development of new therapies in response to the outbreak, Kieny and colleagues began making a framework to speed up development and encourage researchers to share data openly without worrying about being scooped.[15] She commented on the successful development of efficacious vaccines for deployment in a future outbreak.[16] In aftermath of the 2014 Democratic Republic of the Congo Ebola virus outbreak Kieny stated that the vaccine may not be required since the outbreak was not as serious as previously feared.[17] Kieny was involved also in addressing the ongoing antimicrobial resistance crisis with WHO, overseeing the first WHO Model List of Essential Medicines to include guidance on proper use of antibiotics within the framework of universal health care.[18] She helped prepare a list of Antibiotic resistant bacteria which should be prioritised for research beyond just Extensively drug-resistant tuberculosis, such as Acinetobacter baumannii and Pseudomonas aeruginosa strains resistant to Carbapenem.[19] [20] [21]

Kieny was one of seven vaccine experts interviewed in 2012 by Wired about what the next decade held for vaccine innovation.[22]

In 2017 she joined the board of directors for the Human Vaccines Project, was made interim director of the Medicines Patent Pool (MPP), and joined the Drugs for Neglected Diseases Initiative (DNDi) as chief of the board.[23] [24] [25] As head of MPP, Kieny oversaw the licensing of the Hepatitis C drug Mavyret for generic production.[26] [27]

Other activities

Awards

Decorations

Notes and References

  1. Web site: Biography Marie-Paule Kieny - Antivirals Congress - Elsevier. www.elsevier.com. 2019-02-03.
  2. Web site: Marie-Paule Kieny rep el doctorat honoris causa de la UAB pel seu treball per l'accés universal a la salut. es. 2019-02-03.
  3. Web site: Kieny awarded an honorary doctorate for her "undeniable commitment" to the underprivileged. UAB Barcelona. en. 2019-02-03.
  4. Web site: La UAB investirá doctora 'honoris causa' Marie-Paule Kieny por universalizar el acceso a la sanidad. 2019-01-14. La Vanguardia. 2019-02-03.
  5. Web site: La UAB investirá doctora 'honoris causa' Marie-Paule Kieny por universalizar el acceso a la sanidad. Europa Press. 2019-01-14 . 2019-02-03.
  6. Web site: Marie-Paule Kieny European Vaccine Initiative. www.euvaccine.eu. 2019-02-03. 2017-07-12. https://web.archive.org/web/20170712013700/http://www.euvaccine.eu/people/marie-paule-kieny.
  7. Butler. Declan. 2009-05-13. Marie-Paule Kieny. Nature. 10.1038/news.2009.478. 0028-0836.
  8. Web site: Dr. Marie-Paule Kieny Appointed To The Human Vaccines Project Board Of Directors. Human Vaccines Project. www.prnewswire.com. en. 2019-01-27.
  9. Web site: WHO expects around 200,000 Ebola vaccine doses by mid-2015. Nebehay. Stephanie. Kell. Kate. The Irish Times. en. 2019-01-27.
  10. Web site: LSIPR 50 2018: At the head of an experiment in innovation. Newton Media. Life Sciences IP Review. en. 2019-02-03.
  11. Web site: WHO lists bacteria that need to be targeted for antibiotic development. Andalo. Debbie. Pharmaceutical Journal. en. 2019-02-03.
  12. Web site: WHO research and development on Zika. https://web.archive.org/web/20160217092147/http://www.who.int/mediacentre/commentaries/zika-research-development/en/. February 17, 2016. WHO. 2019-03-03.
  13. Web site: Using experimental drugs and vaccines against Ebola is ethical, WHO panel says. Kupferschmidt. Kai. 2014-08-12. Science AAAS. en. 2019-03-03.
  14. Web site: WHO vaccines boss Marie-Paule Kieny signs up as first Ebola trial guinea pig. Sboros. Marika. 2014-10-25. BizNews.com. en-GB. 2019-02-03.
  15. Check Hayden. Erika. 2015-05-28. Ebola teaches tough lessons about rapid research. Nature News. en. 521. 7553. 405–406. 10.1038/521405a. 26017422. free.
  16. Web site: Final trial results confirm Ebola vaccine provides high protection against disease. www.who.int. en. 2019-03-03.
  17. Web site: Ebola outbreak may be smaller than feared, WHO indicates. 2017-05-25. STAT. en-US. 2019-03-03.
  18. Web site: Access, watch, reserve: WHO committee advises when to use common antibiotics. June 7, 2017. www.healio.com. en. 2019-02-03.
  19. Web site: The 12 most dangerous superbugs, ranked by the WHO. Belluz. Julia. Julia Belluz. 2017-02-27. Vox. 2019-03-03.
  20. Web site: WHO's priority list of antibiotic-resistant bacteria looks beyond tuberculosis. Kieny. Marie-Paule. 2017-03-13. STAT. en-US. 2019-03-03.
  21. News: Deadly, Drug-Resistant 'Superbugs' Pose Huge Threat, W.H.O. Says. McNeil, Jr.. Donald G. . 2017-02-27. The New York Times. 2019-03-03. en-US. 0362-4331.
  22. News: The big question: What vaccines will we invent in the next decade?. Venkataramanan. Madhumita. 2012-04-05. Wired UK. 2019-01-27. 1357-0978.
  23. Web site: Leadership And Change: An Interview With Medicines Patent Pool Board Chair Marie-Paule Kieny. 2018-02-08. Intellectual Property Watch. en-US. 2019-01-27.
  24. Web site: Marie-Paule Kieny – DNDi. 2017-08-15. DNDi – Best science for the most neglected. en-GB. 2019-02-03.
  25. Web site: MPP-The Medicines Patent Pool Governance Board Appoints Marie-Paule Kieny as new Chair. en-GB. 2019-02-03.
  26. Web site: Medicines Patent Pool signs license for generic production of Mavyret. December 3, 2018. www.healio.com. en. 2019-03-03.
  27. Web site: AbbVie's Mavyret shows high cure rates. www.thepharmaletter.com. 2019-03-03.
  28. https://www.fondation-merieux.org/en/governance/ Governance
  29. Web site: BioMerieux. www.bloomberg.com. 2019-02-03.
  30. Web site: GISAID - Governance . 2023-04-19 . gisaid.org . en.
  31. Web site: Groundbreaking Global Initiative on Sharing All Influenza Data (GISAID) Celebrates Tenth Anniversary. www.prnewswire.com. en. 2019-03-03.
  32. https://gardp.org/team/ Board of Directors
  33. https://www.jpiamr.eu/about/organisation/management-board/ Management Board
  34. https://www.solthis.org/en/the-board-of-directors/ Board of Directors
  35. https://vsph.tsinghua.edu.cn/en/gywm/International_Advisory_Board.htm Vanke School of Public Health: International Advisory Board
  36. https://wellcome.ac.uk/what-we-do/our-work/vaccines-and-drug-resistant-infections-strategic-advisory-board Strategic Advisory Board on Vaccines and Drug-resistant Infections
  37. https://wellcome.ac.uk/about-us/innovation-advisory-committee Strategic Advisory Board on Innovation
  38. Web site: Marie-Paule Kieny, 2017 International Prize. Inserm - From science to health. en-us. 2019-02-03.
  39. Web site: DNDi Board Chair, Dr Marie-Paule Kieny.
  40. Web site: Marie-Paule Kieny, décorée Chevalier de la Légion d'Honneur. 2019-02-03. Mission de la France. fr.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Marie-Paule Kieny".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.